CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigator Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0649

Testosterone Enanthate Raw

Filed under Raw Materials. The bureau holds 98 laboratory returns for this compound from 31 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

31 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693 A 8 10.0 9.9 10.0 14 Nov 2025 16 Apr 2026
HomopeptideCASE #VI-2026-0760 A 5 10.0 9.9 10.0 24 May 2026 24 May 2026
Shanghai Sigma AudleyCASE #VI-2026-0505 A 4 10.0 9.9 10.0 13 Feb 2026 10 May 2026
Hybio PharmaceuticalCASE #VI-2026-0065 A 4 10.0 9.9 10.0 20 Mar 2026 28 Jun 2026
QYAOBIOCASE #VI-2026-0861 A 3 10.0 10.0 10.0 2 May 2026 5 Jun 2026
Hubei JianxiangCASE #VI-2026-0048 A 3 10.0 9.9 10.0 6 May 2026 12 Jul 2026
GenScript PeptidesCASE #VI-2026-0860 A 3 10.0 10.0 10.0 23 May 2026 16 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142 A 3 10.0 10.0 10.0 24 Mar 2026 8 Jul 2026
SinoPepCASE #VI-2026-0387 A 3 10.0 9.9 10.0 2 Feb 2026 15 Jul 2026
AsymchemCASE #VI-2026-0091 A 3 10.0 9.9 10.0 13 Jan 2026 15 Aug 2026
AmbioPharmCASE #VI-2026-0177 A 3 10.0 10.0 10.0 16 Jun 2026 13 Aug 2026
Kerui PeptidesCASE #VI-2026-0626 A 4 9.9 9.9 10.0 22 Nov 2025 17 Jun 2026
WuXi TIDESCASE #VI-2026-0335 A 4 9.9 9.9 10.0 18 Feb 2026 26 Jun 2026
BachemCASE #VI-2026-0314 A 3 9.9 9.9 10.0 11 Jan 2026 12 May 2026
Mokemei BiotechnologyCASE #VI-2026-0540 A 3 9.9 9.9 10.0 9 Nov 2025 20 Apr 2026
Sigma-AldrichCASE #VI-2026-0829 A 3 9.9 9.9 10.0 28 Dec 2025 3 Aug 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936 A 2 9.9 9.9 10.0 5 May 2026 10 Jun 2026
Sangon BioCASE #VI-2026-0671 A 2 9.9 9.9 10.0 9 May 2026 11 Jun 2026
JEEP PeptidesCASE #VI-2026-0457 A 2 9.9 9.9 10.0 10 Mar 2026 21 May 2026
Flourishglobal PeptideCASE #VI-2026-0630 A 2 9.9 9.9 10.0 15 Feb 2026 8 Mar 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379 A 2 9.9 9.9 10.0 23 Apr 2026 10 May 2026
Chinese Peptide CompanyCASE #VI-2026-0184 A 2 9.9 9.9 10.0 7 Mar 2026 27 Jun 2026
PolyPeptide GroupCASE #VI-2026-0143 A 2 9.9 9.9 9.9 27 Jun 2026 14 Aug 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 A 5 8.6 7.6 9.7 25 May 2026 25 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538 A 4 8.6 8.0 10.0 23 May 2026 23 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704 A 5 8.5 7.8 9.1 24 May 2026 24 May 2026
Peptide TechnologiesCASE #VI-2026-0694 X 1 8.5 8.5 8.5 25 Apr 2025 25 Apr 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 A 4 8.2 7.0 9.2 24 May 2026 24 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486 A 4 8.1 7.4 9.7 24 May 2026 24 May 2026
Haikou Mingheng TechnologyCASE #VI-2026-0250 X 1 3.8 3.8 3.8 27 Feb 2025 27 Feb 2025
Kerisite Shenzhen InternationalCASE #VI-2026-0315 X 1 3.6 3.6 3.6 8 Jul 2025 8 Jul 2025

Open any subject to view the batch-level evidence for Testosterone Enanthate Raw alone.